Malaker, Stacy A. http://orcid.org/0000-0003-2382-5067
Riley, Nicholas M. http://orcid.org/0000-0002-1536-2966
Shon, D. Judy
Pedram, Kayvon http://orcid.org/0000-0001-8365-1826
Krishnan, Venkatesh
Dorigo, Oliver http://orcid.org/0000-0002-1976-5201
Bertozzi, Carolyn R. http://orcid.org/0000-0003-4482-2754
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01CA200423)
Article History
Received: 29 April 2021
Accepted: 30 May 2022
First Online: 20 June 2022
Competing interests
: S.A.M., D.J.S., K.P., and C.R.B. are coinventors on a Stanford nonprovisional utility patent application that has been filed and is pending in the US (number US20220003777) related to the use of inactive mucinases to enrich mucin-domain glycoproteins. C.R.B. is a co-founder and Scientific Advisory Board member of Lycia Therapeutics, Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent), and InterVenn Biosciences, and a member of the Board of Directors of Eli Lilly & Company. O.D. has participated in advisory boards for Tesaro, Merck, and Geneos. O.D. is a speaker for Tesaro and AstraZeneca. The remaining authors declare no competing interests.